Relationship of Mixed Bacterial Infection to Prognosis in Foals with Pneumonia Caused by Rhodococcus equi

Journal of Veterinary Internal Medicine

Volumn 26, Issue 6, 2012, Pages 1443-1448

  Giguere S ^a   Jordan, L M I ^b   Glass, K ^c   Cohen, N D ^c  

^a UNIVERSITY OF GEORGIA   (United States)

^b NewHall Veterinary Centre   (United Kingdom)

^c TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Horse; Tracheobronchial aspirate

Indexed keywords

ACTINOMYCETALES INFECTION; ANIMAL; ANIMAL DISEASE; ARTICLE; BACTERIAL PNEUMONIA; HORSE; HORSE DISEASE; MICROBIOLOGY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RHODOCOCCUS EQUI; RISK;

ACTINOMYCETALES INFECTIONS; ANIMALS; HORSE DISEASES; HORSES; ODDS RATIO; PNEUMONIA, BACTERIAL; PROGNOSIS; RETROSPECTIVE STUDIES; RHODOCOCCUS EQUI;

ANIMALIA; BACTERIA (MICROORGANISMS); EQUIDAE; ESCHERICHIA COLI; FUNGI; NEGIBACTERIA; POSIBACTERIA; RHODOCOCCUS EQUI;

EID: 84869758832     PISSN: 08916640     EISSN: 19391676     Source Type: Journal    
DOI: 10.1111/j.1939-1676.2012.01023.x     Document Type: Article

References (16)

1. Reuss SM, Chaffin MK, Cohen ND. Extrapulmonary disorders associated with Rhodococcus equi infection in foals: 150 cases (1987-2007). J Am Vet Med Assoc 2009;235:855-863.
2. Giguère S, Cohen ND, Chaffin MK, et al. Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals. J Vet Intern Med 2011;25:1209-1220.
3. Jacks S, Giguère S, Nguyen A. In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin and 20 other antimicrobials. Antimicrob Agents Chemother 2003;47:1742-1745.
4. Giguère S, Prescott JF. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 1997;56:313-334.
5. Hines MT. Rhodococcus equi. In: Sellon DC, Long MT, eds. Equine Infectious Diseases. Philadelphia, PA: Saunders; 2007:281-295.
6. Christley RM, Hodgson DR, Rose RJ, et al. Comparison of bacteriology and cytology of tracheal fluid samples collected by percutaneous transtracheal aspiration or via an endoscope using a plugged, guarded catheter. Equine Vet J 1999;31:197-202.
7. Crane SA, Ziemer EL, Sweeney CR. Cytologic and bacteriologic evaluation of tracheobronchial aspirates from clinically normal foals. Am J Vet Res 1989;50:2042-2048.
8. Darien BJ, Brown CM, Walker RD, et al. A tracheoscopic technique for obtaining uncontaminated lower airway secretions for bacterial culture in the horse. Equine Vet J 1990;22:170-173.
9. Hoffman AM, Viel L, Prescott JF. Microbiologic changes during antimicrobial treatment and rate of relapse of distal respiratory tract infections in foals. Am J Vet Res 1993a;54:1608-1614.
10. Hoffman AM, Viel L, Prescott JF, et al. Association of microbiologic flora with clinical, endoscopic, and pulmonary cytologic findings in foals with distal respiratory tract infection. Am J Vet Res 1993b;54:1615-1622.
11. Sweeney CR, Holcombe SJ, Barningham SC, et al. Aerobic and anaerobic bacterial isolates from horses with pneumonia or pleuropneumonia and antimicrobial susceptibility patterns of the aerobes. J Am Vet Med Assoc 1991;198:839-842.
12. Leclere M, Magdesian KG, Kass PH, et al. Comparison of the clinical, microbiological, radiological and haematological features of foals with pneumonia caused by Rhodococcus equi and other bacteria. Vet J 2011;187:109-112.
13. Giguère S, Jacks S, Roberts GD, et al. Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. J Vet Intern Med 2004;18:568-573.
14. Hoquet F, Higgins R, Lessard P, et al. Comparison of the bacterial and fungal flora in the pharynx of normal horses and horses affected with pharyngitis. Can Vet J 1985;26:342-346.
15. Prescott JF, Nicholson VM. The effects of combinations of selected antibiotics on the growth of Corynebacterium equi. J Vet Pharmacol Ther 1984;7:61-64.
16. Nordmann P, Ronco E. In-vitro antimicrobial susceptibility of Rhodococcus equi. J Antimicrob Chemother 1992;29:383-393.